| Cohort |
Smoking Status
|
| Never |
Former |
Current |
|
| NHS, female |
|
|
|
| Incident lung cancer patients, No. |
168 |
711 |
938 |
| Age-truncated AAIR |
15.2 |
76.9 |
293.3 |
| 95% CI |
9.1 to 24.5 |
63.7 to 93.2 |
266.7 to 322.9 |
| Adenocarcinoma, % |
70 |
50 |
42 |
| 95% CI |
62 to 78 |
46 to 54 |
39 to 46 |
| Median age at diagnosis, years |
64 |
68 |
64 |
| HPFS, male |
|
|
|
| Incident lung cancer patients, No. |
43 |
312 |
173 |
| Age-truncated AAIR |
11.2 |
67.6 |
304.5 |
| 95% CI |
6.5 to 19.0 |
56.4 to 82.5 |
277.4 to 334.7 |
| Adenocarcinoma, % |
54 |
51 |
30 |
| 95% CI |
37 to 71 |
45 to 57 |
23 to 39 |
| Median age at diagnosis, years |
67 |
71 |
68 |
| CTS, female |
|
|
|
| Incident lung cancer patients, No. |
91 |
179 |
123 |
| Age-truncated AAIR |
20.8 |
65.6 |
264.4 |
| 95% CI |
13.5 to 31.2 |
54.8 to 79.4 |
240.0 to 291.7 |
| Adenocarcinoma, % |
64 |
54 |
34 |
| 95% CI |
53 to 74 |
46 to 61 |
26 to 43 |
| Median age at diagnosis, years |
67 |
70 |
67 |
| MEC, male* |
|
|
|
| Incident lung cancer patients, No. |
47 |
520 |
511 |
| Age-truncated AAIR |
13.7 |
80.0 |
314.6 |
| 95% CI |
9.0 to 21.5 |
67.1 to 96.1 |
284.6 to 347.7 |
| Adenocarcinoma, % |
53 |
42 |
31 |
| 95% CI |
38 to 68 |
37 to 46 |
27 to 36 |
| Median age at diagnosis, years |
72 |
72 |
69 |
| MEC, female* |
|
|
|
| Incident lung cancer patients, No. |
142 |
270 |
393 |
| Age-truncated AAIR |
20.7 |
65.2 |
233.7 |
| 95% CI |
13.5 to 31.1 |
53.5 to 80.2 |
208.5 to 261.8 |
| Adenocarcinoma, % |
58 |
46 |
32 |
| 95% CI |
49 to 66 |
40 to 52 |
28 to 37 |
| Median age at diagnosis, years |
72 |
70 |
67 |
| U/OLCR, male |
|
|
|
| Incident lung cancer patients, No. |
10 |
124 |
139 |
| Age-truncated AAIR |
4.8 |
59.8 |
173.7 |
| 95% CI |
2.2 to 10.6 |
48.1 to 74.5 |
153.4 to 197.0 |
| Adenocarcinoma, % |
67 |
36 |
34 |
| 95% CI |
30 to 93 |
28 to 45 |
26 to 42 |
| Median age at diagnosis, years |
64 |
71 |
64 |
| U/OLCR, female |
|
|
|
| Incident lung cancer patients, No. |
37 |
68 |
145 |
| Age-truncated AAIR |
14.4 |
51.4 |
149.4 |
| 95% CI |
8.2 to 23.6 |
39.9 to 66.0 |
129.4 to 172.4 |
| Adenocarcinoma, % |
64 |
46 |
38 |
| 95% CI |
46 to 79 |
33 to 58 |
30 to 46 |
| Median age at diagnosis, years |
67 |
66 |
63 |
NHEFS, male |
|
|
|
| Incident lung cancer patients, No. |
4 |
45 |
111 |
| Age-truncated AAIR |
12.7 |
141.4 |
362.7 |
| 95% CI |
10.2 to 18.2 |
124.9 to 161.0 |
334.8 to 393.6 |
| Median age at diagnosis, years |
78 |
72 |
69 |
NHEFS, female |
|
|
|
| Incident lung cancer patients, No. |
15 |
10 |
50 |
| Age-truncated AAIR |
19.3 |
69.1 |
168.8 |
| 95% CI |
14.2 to 27.5 |
57.2 to 84.1 |
146.1 to 194.5 |
| Median age at diagnosis, years |
71 |
67 |
62 |
|